Francisco Valdés Cañedo-rekin lankidetzan egindako argitalpenak (7)

2012

  1. Risk factors for graft loss and mortality after renal transplantation according to recipient age: A prospective multicentre study

    Nephrology Dialysis Transplantation, Vol. 27, Núm. SUPPL.4

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32

2008

  1. Renal transplantation in the modern immunosuppressive era in Spain: Four-year results from a multicenter database focus on post-transplant cardiovascular disease

    Kidney International

2007

  1. Renal Function in Patients With Cadaveric Kidney Transplants Treated With Tacrolimus or Cyclosporine

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2167-2169

2006

  1. Posttransplant Diabetes Mellitus in Renal Allograft Recipients: A Prospective Multicenter Study at 2 Years

    Transplantation Proceedings, Vol. 38, Núm. 10, pp. 3530-3532

2002

  1. Prevention of cardiovascular risk in renal transplantation. Consensus document

    Nefrología : publicación oficial de la Sociedad Española Nefrologia

1994

  1. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: A multicenter randomized study

    Transplantation Proceedings